|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Evidence for altered vascular responses to exogenous endothelin-1 in patients with advanced cirrhosis with restoration of the normal vasoconstrictor response following successful liver transplantation显示文摘 | Vaughan R B Angus P W Chin Dusting J P F | 2003 | Gut2003，52，10： | 1 |
| 2 | Continuous Hydrothermal Synthesis of CoFe2O4 Nanoparticles显示文摘 | Linda J C Amyn S T Angus P W | 2003 | Fluid Phase Equilibria2003，210，2： | 1 |
| 3 | A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis 显示文摘 | Angus P W Patterson S J Strasser S I | 2008 | Hepatology2008，48，5： | 1 |
| 4 | Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B 显示文摘 | ANGUS P W MCCAUGHAN G GANE E J | 2000 | Liver Transpl2000，6，4： | 1 |
| 5 | Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro显示文摘 | McMillian J S Shaw T Angus P W | 1995 | Hepatology1995，22，： | 1 |
| 6 | Hepatitis B and C virus infections and anti-tumor necrosis factor a therapy: guidelines for clinical approach 显示文摘 | NATHAN D M ANGUS P W GIBSON P R | 2006 | J Gastroenterol Hepatol2006，21，9： | 1 |
| 7 | Raising the yield potential 显示文摘 | Reynolds M Foulkes M J Slafer G A Berry P Parry M A J Shape J W Angus W J | 2009 | J Exp Bot2009，60，： | 1 |
| 8 | Selective inhibition of synthesis of enzymes for de novo fatty acid biosynthesis by an endotoxin-induced mediator from exudate cells显示文摘 | PEKALA P H KAWAKAMI M ANGUS C W | 1983 | Proceedings of the National Academy of Sciences of the United States of America1983，80，9： | 1 |
| 9 | Im- munization With a DNA Plasmid Encoding the SAG1 (P30) Protein of Toxoplasma gondii Is Immunogenic and Protec- tive lnrodents显示文摘 | Angus C W Klivington - Evans D Dubey J P | 2000 | J Infect Dis2000，181，： | 1 |
| 10 | Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver 显示文摘 | SARIN S K KUMAR A ANGUS P W | 2005 | Hepatol Int2005，2，4： | 1 |
| 11 | Effect of immuneosuppressive and antiviral agents on hepatitis B virus replication in vitro显示文摘 | Mc Millan JS Shaw T Angus P W | 1995 | Hepatology1995，22，1： | 1 |
| 12 | Primary prophylaxis of gastroesophageal variceal bleeding:consensus recommendations of the Asian Pacific Association for the study of the liver显示文摘 | Sarin S K Kumar A Angus P W | 2008 | Hepatol Int2008，2，4： | 1 |
| 13 | Epidemiology and outcomes of acute liver failure in Australia显示文摘BACKGROUND Acute liver failure (ALF) is a life-threatening syndrome with varying aetiologies requiring complex care and multidisciplinary management. Its changing incidence, aetiology and outcomes over the last 16 years in the Australian context remain uncertain. AIM To describe the changing incidence, aetiology and outcomes of ALF in South Eastern Australia. METHODS The database of the Victorian Liver Transplant Unit was interrogated to identify all cases of ALF in adults (> 16 years) in adults hospitalised between January 2002 and December 2017. Overall, 169 patients meeting criteria for ALF were identified. Demographics, aetiology of ALF, rates of transplantation and outcomes were collected for all patients. Transplant free survival and overall survival (OS) were assessed based on survival to discharge from hospital. Results were compared to data from a historical cohort from the same unit from 1988- 2001. RESULTS Paracetamol was the most common aetiology of acute liver failure, accounting for 50% of cases, with an increased incidence compared with the historical cohort (P = 0.046). Viral hepatitis and non-paracetamol drug or toxin induced liver injury accounted for 15% and 10% of cases respectively. Transplant free survival (TFS) improved significantly compared to the historical cohort (52% vs 38%, P = 0.032). TFS was highest in paracetamol toxicity with spontaneous recovery in 72% of cases compared to 31% of non-paracetamol ALF (P < 0.001). Fifty-nine patients were waitlisted for emergency liver transplantation. Nine of these died while waiting for an organ to become available. Forty-two patients (25%) underwent emergency liver transplantation with a 1, 3 and 5 year survival of 81%, 78% and 72% respectively. CONCLUSION Paracetamol toxicity is the most common aetiology of ALF in South-Eastern Australia with a rising incidence over 30 years. TFS has improved, however it remains low in non-paracetamol ALF. | Penelope Hey Timothy P Hanrahan Marie Sinclair Adam G Testro Peter W Angus Adam Peterson Stephen Warrillow Rinaldo Bellomo Marcos V Perini Graham Starkey Robert M Jones Michael Fink Tess McClure Paul Gow | 2019 | World Journal of Hepatology2019，11，7： | 1 |
| 14 | Effect of immunosuppressive and antiviral agents on Hepatitis B virus replication in vitro显示文摘 | MCMILLAN J S SHAW T ANGUS P W | 1995 | Hepatology1995，22，1： | 1 |
| 15 | Combination low-dose hepatitis B immune globulin(HBIG) and lamivudine therapy provides effective prophylaxis against post-transplant hepatitis B显示文摘 | ANGUS P W MCCAUGHAN G W GANE E J | 2000 | Liver Transpl2000，6，： | 1 |
| 16 | Effect of immuno-suppressive and antiviral agents on hepatitis B virus replication in vitro显示文摘 | McMillan J S Shaw T Angus P W | 1995 | Hepatology1995，22，1： | 1 |
| 17 | Up-regulation of components of therenin-angiotensin system in the bile duct-ligated rat liv-er显示文摘 | Paizis G Cooper M E Schembri J M?Tikellis C BurrellL M Angus P W | 2002 | Gastroenterology?2002，123，： | 1 |
| 18 | Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine 显示文摘 | Tenney DJ Levine SM Rose RE Walsh AW Weinheimer SP Discotto L Plym M Pokornowski K Yu CF Angus P Ayres A Bartholomeusz A Sievert W Thompson G Warner N Locarnini S Colonno ILl | 2004 | Antimicrob Agents Chemother2004，48，9： | 1 |
| 19 | Modern management of portal hypertension显示文摘 | Lubel J S Angus P W | 2005 | Intern Med J2005，35，1： | 1 |
| 20 | Hepatitis B reactivation in patients receiv- ing cytotoxic chemotherapy: diagnosis and management显示文摘 | Lubel J S Angus P W | 2010 | J Gastroenterol Hepatol2010，25，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员